These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 10933399)
1. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Lyons PA; Hancock WW; Denny P; Lord CJ; Hill NJ; Armitage N; Siegmund T; Todd JA; Phillips MS; Hess JF; Chen SL; Fischer PA; Peterson LB; Wicker LS Immunity; 2000 Jul; 13(1):107-15. PubMed ID: 10933399 [TBL] [Abstract][Full Text] [Related]
2. Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region. Irie J; Wu Y; Sass DA; Ridgway WM Immunogenetics; 2006 Feb; 58(1):9-14. PubMed ID: 16425035 [TBL] [Abstract][Full Text] [Related]
3. Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes. Cannons JL; Chamberlain G; Howson J; Smink LJ; Todd JA; Peterson LB; Wicker LS; Watts TH J Autoimmun; 2005 Aug; 25(1):13-20. PubMed ID: 15998581 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2. Siegmund T; Armitage N; Wicker LS; Peterson LB; Todd JA; Lyons PA Diabetes; 2000 Sep; 49(9):1612-6. PubMed ID: 10969850 [TBL] [Abstract][Full Text] [Related]
5. The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model. Kachapati K; Adams DE; Wu Y; Steward CA; Rainbow DB; Wicker LS; Mittler RS; Ridgway WM J Immunol; 2012 Nov; 189(10):5001-15. PubMed ID: 23066155 [TBL] [Abstract][Full Text] [Related]
6. Congenic mapping identifies a novel Idd9 subregion regulating type 1 diabetes in NOD mice. Lin B; Ciecko AE; MacKinney E; Serreze DV; Chen YG Immunogenetics; 2017 Mar; 69(3):193-198. PubMed ID: 27796442 [TBL] [Abstract][Full Text] [Related]
7. Combined congenic mapping and nuclease-based gene targeting for studying allele-specific effects of Tnfrsf9 within the Idd9.3 autoimmune diabetes locus. Forsberg MH; Foda B; Serreze DV; Chen YG Sci Rep; 2019 Mar; 9(1):4316. PubMed ID: 30867509 [TBL] [Abstract][Full Text] [Related]
8. The type 1 diabetes resistance locus B10 Idd9.3 mediates impaired B-cell lymphopoiesis and implicates microRNA-34a in diabetes protection. Berry GJ; Budgeon LR; Cooper TK; Christensen ND; Waldner H Eur J Immunol; 2014 Jun; 44(6):1716-27. PubMed ID: 24752729 [TBL] [Abstract][Full Text] [Related]
12. Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes. Walter U; Franzke A; Sarukhan A; Zober C; von Boehmer H; Buer J; Lechner O Eur J Immunol; 2000 Apr; 30(4):1224-32. PubMed ID: 10760812 [TBL] [Abstract][Full Text] [Related]
13. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice. Robles DT; Eisenbarth GS; Dailey NJ; Peterson LB; Wicker LS Diabetes; 2003 Mar; 52(3):882-6. PubMed ID: 12606534 [TBL] [Abstract][Full Text] [Related]
14. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Hill NJ; Lyons PA; Armitage N; Todd JA; Wicker LS; Peterson LB Diabetes; 2000 Oct; 49(10):1744-7. PubMed ID: 11016460 [TBL] [Abstract][Full Text] [Related]
15. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice. Wicker LS; Miller BJ; Chai A; Terada M; Mullen Y J Exp Med; 1988 Jun; 167(6):1801-10. PubMed ID: 3290380 [TBL] [Abstract][Full Text] [Related]
16. The autoimmune diabetes locus Idd9 regulates development of type 1 diabetes by affecting the homing of islet-specific T cells. Waldner H; Sobel RA; Price N; Kuchroo VK J Immunol; 2006 May; 176(9):5455-62. PubMed ID: 16622013 [TBL] [Abstract][Full Text] [Related]